ProMIS Neurosciences

PMNNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$131.915 M

$14.71 +10.35%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$39.7M

Loss-making

Shares outstanding

8,967,693

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#292EquilliumEQ$133.4M
#293InflaRxIFRX$133.0M
#294ProMIS NeurosciencesPMN$131.9M
#295NRX PharmaceuticalsNRXP$129.7M
#296Spruce BiosciencesSPRB$129.0M

Where these numbers come from

Share counts and financials for ProMIS Neurosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.